Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT01230476Phase 2Terminated
- Sponsor
- Universiti Malaya
- Start
- May 2010
- Primary completion
- May 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in nasopharyngeal carcinoma (NPC), sponsored by Universiti Malaya. Started May 2010; status: terminated.
02
Drugs
cetuximab
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01230476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01230476.